| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.044 | 0.4 |